Taking biotechnology, medical device, and animal health products through development and regulatory approval
 

It takes a lot to get from bench...

 
bigstock-Chemical-Laboratory-Like-Backg-110981114.jpg
 

...To bedside.

 
 
 
bigstock-Operating-Room-In-Cardiac-Surg-72495166.jpg
 
 

we make the hand off easier

We are a group of experienced healthcare innovators located in Nashville, TN.

Relay Life Science acquires promising technologies from the medical device, biotech, pharmaceutical and animal health sectors and drives them through the development pathway to acquisition.

 

 
 
Relay metaphor-01.png

1. Discovery/Research

A researcher or clinician develops an idea past the proof of concept phase and begins the intellectual property process.

 
 
 
Relay metaphor-02.png

2. Development

Relay Life Science acquires the technology, then validates, develops and refines it.

 
 
 
Relay metaphor-03.png

3. Market Readiness

Relay Life Science drives the innovation through any necessary clinical studies and regulatory clearance/approval.

 
 
 

4. Commercialization

The technology is positioned for acquisition by a large commercialization partner.

 
 
 

Creating a successful life science product is like a relay race. We take on the middle "legs" of product development.

We validate and expand on promising ideas discovered by researchers and clinicians. We develop these ideas to become a commercially viable product, moving them through the regulatory process.

By running these intermediate "legs", Relay Life Science creates the possibility of significant return for the inventor and investors, while de-risking the technology for the acquirer.

 

 
 
 
 
 

Why Work With Relay?

Our product isn't just the technology in our portfolio. It's also our team. We have deep experience in the full scope of life science product development and commercialization. We have a track record of success leading products through the most difficult of designations to obtain regulatory approval. Our experience includes medical devices, drugs, and biologics.

 
 
Jim Monsor Jim has more than 30 years of drug, device, biologics development and commercialization experience. Most recently he served as head of operations for BioMimetic Therapeutics for twelve years; leading growth from four to 100 employees. He built and led operations and quality functions, and led multiple product development and commercialization programs. Prior to joining BMTI, Jim spent fifteen years at Abbott Laboratories and served as Director of Product Supply at ALK-Abello. He has broad experience in commercial operations, supply chain management, product development, quality, regulatory, IT, and facilities management for drug, device, biologics, combination products, and bulk drug products. His experience spans early stage research through all phases of development, product launches, and routine commercial operations. He is also Director of the Life Science TN Mentor Program and an active member of NueCura Partners angel investment group. 

Jim Monsor

Jim has more than 30 years of drug, device, biologics development and commercialization experience. Most recently he served as head of operations for BioMimetic Therapeutics for twelve years; leading growth from four to 100 employees. He built and led operations and quality functions, and led multiple product development and commercialization programs. Prior to joining BMTI, Jim spent fifteen years at Abbott Laboratories and served as Director of Product Supply at ALK-Abello. He has broad experience in commercial operations, supply chain management, product development, quality, regulatory, IT, and facilities management for drug, device, biologics, combination products, and bulk drug products. His experience spans early stage research through all phases of development, product launches, and routine commercial operations. He is also Director of the Life Science TN Mentor Program and an active member of NueCura Partners angel investment group. 

Jim MonsoR

Russell Pagano Dr. Pagano has over 20 years of experience in the medical device/biologics industry.  Russ joined Biomimetic Therapeutics in 2007 as Vice President, Clinical and Regulatory Affairs, and served in that role until January 2016.  During those 9 years, he oversaw the product development pathway of a combination product containing a recombinant human protein and a synthetic bone void filler.  He remained with the company through the product’s FDA approval and commercial launch.  Prior to BioMimetic, he cofounded a clinical and regulatory consulting company based in Washington DC.  He started his career working for the FDA.  At the FDA, he spent seven years in the Office of Device Evaluation as a Reviewer in the Urology, Gastroenterology, and Lithotripsy Devices Branch; Branch Chief of the Restorative Devices Branch (which included, among other devices, combination products containing growth factors, therapeutic neurology devices, and sports medicine products); and Branch Chief of the Pacing, Defibrillator and Leads Branch.  He received his Ph.D. in Mechanical Engineering and Materials Science from Duke University.

Russell Pagano

Dr. Pagano has over 20 years of experience in the medical device/biologics industry.  Russ joined Biomimetic Therapeutics in 2007 as Vice President, Clinical and Regulatory Affairs, and served in that role until January 2016.  During those 9 years, he oversaw the product development pathway of a combination product containing a recombinant human protein and a synthetic bone void filler.  He remained with the company through the product’s FDA approval and commercial launch.  Prior to BioMimetic, he cofounded a clinical and regulatory consulting company based in Washington DC.  He started his career working for the FDA.  At the FDA, he spent seven years in the Office of Device Evaluation as a Reviewer in the Urology, Gastroenterology, and Lithotripsy Devices Branch; Branch Chief of the Restorative Devices Branch (which included, among other devices, combination products containing growth factors, therapeutic neurology devices, and sports medicine products); and Branch Chief of the Pacing, Defibrillator and Leads Branch.  He received his Ph.D. in Mechanical Engineering and Materials Science from Duke University.

Russell Pagano

Marcus Henschen Marcus is a registered nurse and healthcare entrepreneur. He has more than 5 years of clinical experience in a variety of healthcare settings, where he has worked to identify inefficiencies as a means to develop improved medical devices. In 2014, Marcus founded Epikardis Medical, where he led an innovation through early development to a licensing agreement with a large strategic partner. In addition, he has consulted with biotech startups and been involved with numerous accelerators and business incubators.

Marcus Henschen

Marcus is a registered nurse and healthcare entrepreneur. He has more than 5 years of clinical experience in a variety of healthcare settings, where he has worked to identify inefficiencies as a means to develop improved medical devices. In 2014, Marcus founded Epikardis Medical, where he led an innovation through early development to a licensing agreement with a large strategic partner. In addition, he has consulted with biotech startups and been involved with numerous accelerators and business incubators.

Marcus Henschen

 
Relay-color-background3.png
 

what we are looking for

Relay metaphor-01.png

Relay Life Science is interested in acquiring technologies that have meaningful commercial potential. Get in touch if you have an idea and want to learn more about how we might help move your concept forward.

 
 

researchers/Clinicians

Contact us if you have a discovery that might be commercially viable but you aren't interested in starting your own company or your market research shows your idea can't sustain a standalone company.

Tech Transfer

Contact us if you have viable technologies in your portfolio that need a commercial development pathway.

 
 
 
 

Do not submit anything that is confidential or proprietary. We will discuss non-disclosure agreements in subsequent conversations.

 
 

ACQUIRE OUR TECHNOLOGY

 

Contact us if you...

  • Are involved in the life sciences industry and wish to learn more about the Relay product development pipeline.

 

  • Are an established company in our target industry sectors seeking validated technologies to expand your commercial product portfolio. 
 
 
 
Relay-color-background3.png